The worlds biggest dementia study was launched in the UK Thursday and will analyze data from more than two million people to try and find new treatments for the littleunderstood disease including its commonest form Alzheimers The study  a  million publicprivate partnership  forms part of coordinated G efforts to target dementia and will be run by the UKs publiclyfunded Medical Research Council with support from several drug makers  AstraZeneca GlaxoSmithKline and Janssen Research and Development a unit of Johnson  Johnson